A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients On Metformin Treatment(SUPER-2)
Clinical trial NCT04998032 · COMPLETED
Trial details
- NCT number
- NCT04998032
- Sponsor
- Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-12
- Primary completion
- 2023-06-15
- Enrollment
- 620
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.